Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours

Navigating cancer treatment choices

Choosing the right Tyrosine Kinase Inhibitors (TKI) for CML Patients

Transforming childhood cancer treatment: key insights

Navigating breast cancer treatment for young patients

Advancements in head and neck cancer treatment in India

Multiple Myeloma: evolving paradigm - Panel Discussion

New NK-1 inhibitor HR20013 shows promising results in preventing chemotherapy-induced nausea and vomiting in NSCLC patients

Advancements in paediatric Acute lymphoblastic leukemia management

Enhancing head and neck oncology: Key insights from the conference

Tusamitamab ravtansine versus docetaxel in previously treated advanced nonsquamous NSCLC: Results from phase 3 CARMEN-LC03 trial

Cemiplimab monotherapy could be a new treatment option for first line advanced NSCLC patients